Skip to main content
. Author manuscript; available in PMC: 2012 Jun 1.
Published in final edited form as: J Neurol Phys Ther. 2011 Jun;35(2):90–97. doi: 10.1097/NPT.0b013e31821a620c

Table 1.

Comparison of overall subjects, fallers, and non-fallers.

Overall (n=80)
Mean ± SD
Fallers (n=25)
Mean ± SD
Non-Fallers (n=55)
Mean ± SD
% male 59% 64% 56%
Age 68.2 ± 9.3 68.8 ± 7.8 67.9 ± 10.0
Disease duration 8.5 ±.54 11.4 ± 5.5* 7.15 ± 3.81
MDS-UPDRS score 72.6 ± 25.1 93.8 ± 23.1* 62.9 ± 19.0
H&Y stage-mean (SD)/median 2.45 ± 0.64/2.5 2.9 ± 0.71/3.0* 2.3 ± 0.50/2.0
Stage 1 4 1 3
Stage 2 27 1 26
Stage 2.5 30 10 20
Stage 3 13 8 5
Stage 4 6 5 1
Mini-BESTest 20.2 ± 7.0 14.3 ± 6.2* 22.9 ± 5.5
Mini-BESTest % 63.2 ± 21.8 44.8 ± 19.4* 71.6 ± 17.3
BESTest Total % 70.3 ± 16.7 57.1 ± 15.4 * 76.4 ± 13.6
Section I: Biomechanical Constraints % 59.2 ± 22.3 45.3 ± 19.4* 65.6 ± 20.7
Section II: Stability Limits/Verticality % 80.1 ± 12.6 73.9 ± 11.8 82.9 ± 12.1
Section III : Anticipatory Postural Adjustments % 69.5 ± 20.4 57.6 ± 18.4* 74.9 ± 18.9
Section IV: Postural Responses % 68.5 ± 22.9 52.2 ± 25.6* 75.9 ± 18.0
Section V: Sensory Orientation % 75.3 ± 22.4 58.9 ± 24.9* 82.7 ± 16.8
Section VI: Stability in Gait % 68.0 ± 21.5 51.4 ± 20.6* 75.5 ± 17.4

Statistically significant difference between fallers and non-fallers

*

(p<0.001) and

(p<0.004).